BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37047582)

  • 1. Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer.
    Marcelo GA; Montpeyó D; Galhano J; Martínez-Máñez R; Capelo-Martínez JL; Lorenzo J; Lodeiro C; Oliveira E
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
    Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer.
    Marcelo GA; Galhano J; Robalo TT; Cruz MM; Marcos MD; Martínez-Máñez R; Duarte MP; Capelo-Martínez JL; Lodeiro C; Oliveira E
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP
    Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells.
    Fang F; Zhang X; Tang J; Wang Y; Xu J; Sun Y
    Chem Phys Lipids; 2023 Mar; 251():105280. PubMed ID: 36634728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
    Galhano J; Marcelo GA; Duarte MP; Oliveira E
    Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy.
    Emami F; Banstola A; Vatanara A; Lee S; Kim JO; Jeong JH; Yook S
    Mol Pharm; 2019 Mar; 16(3):1184-1199. PubMed ID: 30698975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
    Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
    Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy.
    Wang JK; Zhou YY; Guo SJ; Wang YY; Nie CJ; Wang HL; Wang JL; Zhao Y; Li XY; Chen XJ
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():944-950. PubMed ID: 28482611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
    Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
    J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.
    Chen R; Huang Y; Wang L; Zhou J; Tan Y; Peng C; Yang P; Peng W; Li J; Gu Q; Sheng Y; Wang Y; Shao G; Zhang Q; Sun Y
    Biomater Sci; 2021 Mar; 9(6):2279-2294. PubMed ID: 33538278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
    Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
    Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
    El Hallal R; Lyu N; Wang Y
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.
    Kopansky E; Shamay Y; David A
    J Drug Target; 2011 Dec; 19(10):933-43. PubMed ID: 22074249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
    Rodrigues JG; Duarte HO; Gomes C; Balmaña M; Martins ÁM; Hensbergen PJ; de Ru AH; Lima J; Albergaria A; van Veelen PA; Wuhrer M; Gomes J; Reis CA
    Cell Oncol (Dordr); 2021 Aug; 44(4):835-850. PubMed ID: 33847896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
    Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
    Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
    Park C; Baek N; Loebenberg R; Lee BJ
    J Control Release; 2020 Aug; 324():55-68. PubMed ID: 32380202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.